This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Walter Louis Antoine Verstappen: Innovator in Pharmaceutical Chemistry
Introduction
Walter Louis Antoine Verstappen is a notable inventor based in Kontich, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex compounds. His work is essential for the development of innovative therapeutic agents.
Latest Patents
Walter Verstappen holds a patent for the synthesis of (2S-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3-dioxolane-4-methanol methanesulfonate(ester). This invention relates to an improved process for preparing this key intermediate, which is crucial for the development of the apoB secretion/MTP inhibitor mitratapide. His patent is a testament to his expertise and dedication to advancing pharmaceutical science. He has 1 patent to his name.
Career Highlights
Walter Verstappen is associated with Janssen Pharmaceutica, a leading company in the pharmaceutical industry. His role at Janssen has allowed him to work on groundbreaking projects that aim to improve health outcomes through innovative drug development. His contributions have been instrumental in the company's research initiatives.
Collaborations
Walter has collaborated with esteemed colleagues, including Walter Ferdinand Maria Filliers and Ronny Bellinkx. These partnerships have fostered a collaborative environment that enhances the research and development process within the pharmaceutical sector.
Conclusion
Walter Louis Antoine Verstappen is a distinguished inventor whose work in pharmaceutical chemistry has made a significant impact. His innovative approach to synthesis and collaboration with industry experts exemplifies the spirit of scientific advancement. His contributions continue to pave the way for future developments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile